litlas
Log inCreate account

Harry Bartelink

Active 1983–2024

113
Papers
33,190
Citations
88
h-index
110
i10-index

Citations

Citations per year for Harry Bartelink1972: 1 citations1974: 1 citations1984: 1 citations1985: 1 citations1986: 4 citations1987: 4 citations1988: 4 citations1989: 9 citations1990: 16 citations1991: 13 citations1992: 26 citations1993: 32 citations1994: 28 citations1995: 48 citations1996: 36 citations1997: 39 citations1998: 57 citations1999: 64 citations2000: 66 citations2001: 121 citations2002: 118 citations2003: 208 citations2004: 226 citations2005: 290 citations2006: 316 citations2007: 376 citations2008: 374 citations2009: 350 citations2010: 440 citations2011: 338 citations2012: 308 citations2013: 306 citations2014: 225 citations2015: 247 citations2016: 211 citations2017: 203 citations2018: 196 citations2019: 553 citations2020: 548 citations2021: 441 citations2022: 333 citations2023: 190 citations2024: 290 citations2025: 106 citations2026: 5 citations1973: no citations, so this year is not shown1975–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,967 citing papers, 28.5% of this breakdownNetherlands: 768 citing papers, 7.4% of this breakdownUnited Kingdom: 725 citing papers, 7% of this breakdownChina: 554 citing papers, 5.3% of this breakdownGermany: 506 citing papers, 4.8% of this breakdownFrance: 487 citing papers, 4.7% of this breakdownItaly: 482 citing papers, 4.6% of this breakdownCanada: 455 citing papers, 4.4% of this breakdownBelgium: 293 citing papers, 2.8% of this breakdownAustralia: 271 citing papers, 2.6% of this breakdownSwitzerland: 271 citing papers, 2.6% of this breakdownSpain: 215 citing papers, 2.1% of this breakdown
0%28.5%Other 23.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology45.3%
  • Medicine43.4%
  • Physics and Astronomy3.3%
  • Computer Science2.5%
  • Mathematics1.1%
  • Engineering1%
  • Other3.4%

Topics

  • Breast Cancer Treatment Studies10.2%
  • Breast Lesions and Carcinomas4%
  • Gene expression and cancer classification3.8%
  • Advanced Radiotherapy Techniques2.8%
  • Breast Implant and Reconstruction2.8%
  • Bioinformatics and Genomic Networks2.3%
  • Other74.1%

Coauthors

All papers

Open in search
  1. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    Authors: Marc J. van de Vijver, Yudong D. He, Laura van ‘t Veer, Hongyue Dai, Augustinus A. M. Hart, Dorien W. Voskuil, George J. Schreiber, Johannes L. Peterse, Chris Roberts, Matthew J. Marton, Mark L Parrish, Douwe E. Atsma, Anke Witteveen, Annuska M. Glas, Leonie Delahaye, Tony van der Velde, Harry Bartelink, Sjoerd Rodenhuis, Emiel T. Rutgers, Stephen Friend, René Bernards - New England Journal of Medicine 2002 cited by 6,520

  2. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Authors: Richard J. Gray, Rosie Bradley, Jeremy Braybrooke, Zulian Liu, Richárd Pető, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, William E. Barlow, Judith M. Bliss, Paolo Bruzzi, David Cameron, George Fountzilas, Sibylle Loibl, John R. Mackey, Miguel Martín, Lucia Del Mastro, Volker Möbus, Valentina Nekljudova, Sabino De Placido, Sandra M. Swain, Michael Untch, Kathleen I. Pritchard, Jonas Bergh, Larry Norton, Clare Boddington, Julie Ann Burrett, Mike Clarke, Christina Davies, Frances Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert K. Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, J.-M. Nogaret, C. Philippson, Martine Piccart, Sabine C. Linn, Petronella G.M. Peer, Vivianne C. G. Tjan‐Heijnen, S.B. Vliek, John R. Mackey, Dennis Slamon, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond L. Weiss, Yi Shan, Yong fu Shao, Xiang Wang, Binghe Xu, Dongbing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fátima Cardoso, Tanja Čufer, Jean‐Pierre Julien, Philip Poortmans, Emiel J. Rutgers, Cornelis J.�H. van de Velde, Eva Carrasco, Miguel Ángel Seguí, Jens‐Uwe Blohmer, Serban Dan Costa, Bernd Gerber and 67 more - The Lancet 2019 cited by 394

  3. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

    Authors: Benjamin Lacas, Jean Bourhis, Jens Overgaard, Qiang Zhang, Vincent Grégoire, Matthew Nankivell, Björn Zackrisson, Z. Szutkowski, Rafał Suwiński, Michael Poulsen, Brian O’Sullivan, Renzo Corvò, Sarbani Ghosh Laskar, C. Fallai, Hideya Yamazaki, W. Dobrowsky, Kwan Ho Cho, Beth M. Beadle, Johannes A. Langendijk, Célia M. Viégas, John Hay, Mohamed Lotayef, Mahesh Parmar, Anne Aupérin, Carla van Herpen, P. Maingon, Andy Trotti, Cai Grau, Jean‐Pierre Pignon, Pierre Blanchard, Pierre Blanchard, Jean Bourhis, Benjamin Lacas, Jean‐Pierre Pignon, Jacques Bernier, Quynh‐Thu Le, Jens Overgaard, Masheh KB Parmar, Andy Trotti, Jai Prakash Agarwal, Anne Aupérin, Kian Ang, Hassan K. Awwad, Almalina Bacigalupo, Harry Bartelink, E Benhamou, Jacques Bernier, Pierre Blanchard, Jean Bourhis, Wilfried Budach, Imjai Chitapanarux, Kwan Ho Cho, Laurence Collette, Renzo Corvò, Carla Dani, Stanley Dische, W. Dobrowsky, James W. Denham, C.M.L. Driessen, C. Fallai, Beth M. Beadle, Sarbani Ghosh Laskar, Sushmita Ghoshal, Cai Grau, Vincent Grégoire, John Hay, Carla van Herpen, A Hliniak, Jørgen Johansen, Claus Andrup Kristiansen, Valentina Krstevska, Benjamin Lacas, Johannes A. Langendijk, M. Lapeyre, Quynh‐Thu Le, Mohamed Lotayef, B. Maciejewski, P. Maingon, Wojciech Michalski, Sung Ho Moon, Per Nilsson, Patrizia Olmi, Matthew Nankivell, Kinji Nishiyama, Brian O’Sullivan, Jens Overgaard, Mahesh Parmar, Jean‐Pierre Pignon, Michael Poulsen, Kunnambath Ramadas, Anupam Rishi, David I. Rosenthal, Giuseppe Sanguineti, Michele I. Saunders, Christian Sire, Krzysztof Składowski, Luís Souhami, Rafał Suwiński, Z. Szutkowski, Nitin Tandon and 12 more - The Lancet Oncology 2017 cited by 339

  4. Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer

    Authors: Maartje J. Hooning, Akke Botma, Berthe M.P. Aleman, Margreet H.A. Baaijens, Harry Bartelink, Jan G.M. Klijn, Carolyn Taylor, Flora E. van Leeuwen - JNCI Journal of the National Cancer Institute 2007 cited by 871

  5. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial

    Authors: Harry Bartelink, P. Maingon, Philip Poortmans, Caroline Weltens, Alain Fourquet, J.J. Jager, Dominic A.X. Schinagl, Bing Oei, C.C. Rodenhuis, J.C. Horiot, H. Struikmans, Erik Van Limbergen, Youlia Kirova, Paula H.M. Elkhuizen, Rudolf Bongartz, Raymond Miralbell, D.A.L. Morgan, Jean-Bernard Dubois, Vincent Remouchamps, René-Olivier Mirimanoff, Sandra Collette, Laurence Collette - The Lancet Oncology 2014 cited by 682

  6. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial

    Authors: Philip Poortmans, Caroline Weltens, Catherine Fortpied, Carine Kirkove, K. Peignaux-Casasnovas, Volker Budach, Femke van der Leij, Ernest Vonk, N. Weidner, Sofía Rivera, Geertjan van Tienhoven, Alain Fourquet, G. Noël, Mariacarla Valli, Matthias Gückenberger, Eveline Koiter, S. Racadot, Roxolyana Abdah‐Bortnyak, Erik F Van Limbergen, Antoine Engelen, Peter De Brouwer, H. Struikmans, Harry Bartelink - The Lancet Oncology 2020 cited by 288

  7. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer

    Authors: Philip Poortmans, Sandra Collette, Carine Kirkove, Erik Van Limbergen, Volker Budach, H. Struikmans, Laurence Collette, Alain Fourquet, P. Maingon, Mariacarla Valli, K. De Winter, Simone Marnitz, I. Barillot, Luciano Scandolaro, Ernest Vonk, C.C. Rodenhuis, H. Marsiglia, N. Weidner, Geertjan van Tienhoven, Christoph Glanzmann, Abraham Kuten, R. Arriagada, Harry Bartelink, Walter Van den Bogaert - New England Journal of Medicine 2015 cited by 1,021

  8. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

    Authors: Harry Bartelink, F. Roelofsen, F. Eschwège, P Rougier, Jean-François Bosset, D. González González, D. Peiffert, M. van Glabbeke, M. Piérart - Journal of Clinical Oncology 1997 cited by 1,318

  9. Late cardiotoxicity after treatment for Hodgkin lymphoma

    Authors: Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Marie L. De Bruin, Mars B. van ’t Veer, Margreet H.A. Baaijens, Jan Paul de Boer, Augustinus A. M. Hart, Willem J. Klokman, Marianne A. Kuenen, Gabey M. Ouwens, Harry Bartelink, Flora E. van Leeuwen - Blood 2006 cited by 766

  10. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer

    Authors: Corey Speers, Shuang Zhao, Meilan Liu, Harry Bartelink, Lori J. Pierce, Felix Y. Feng - Clinical Cancer Research 2015 cited by 188

  11. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

    Authors: Bas Kreike, Marieke van Kouwenhove, Hugo M. Horlings, Britta Weigelt, Hans Peterse, Harry Bartelink, Marc J. van de Vijver - Breast Cancer Research 2007 cited by 609

  12. Increased Risk of Ischemic Stroke After Radiotherapy on the Neck in Patients Younger Than 60 Years

    Authors: Lucille D.A. Dorresteijn, A.C. Kappelle, Willem Boogerd, Willem J. Klokman, Alfons J. M. Balm, Ronald B. Keus, Flora E. van Leeuwen, Harry Bartelink - Journal of Clinical Oncology 2002 cited by 249

  13. Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

    Authors: C. Schaake-Koning, Walter Van den Bogaert, Otilia Dalesio, Jan Festen, Jaap Hoogenhout, Paul Van Houtte, Anne Kirkpatrick, Mia G.J. Koolen, B. Maat, A. Nijs, Alain Renaud, Patrick Rodrigus, Lon Schuster-Uitterhoeve, Jean‐Paul Sculier, Nico van Zandwijk, Harry Bartelink - New England Journal of Medicine 1992 cited by 1,287

  14. Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

    Authors: Harry Bartelink, Jean-Claude Horiot, Philip Poortmans, H. Struikmans, Walter Van den Bogaert, Alain Fourquet, J.J. Jager, W.J. Hoogenraad, S.B. Oei, Carla C. Wárlám-Rodenhuis, M. Piérart, Laurence Collette - Journal of Clinical Oncology 2007 cited by 1,046

  15. Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation

    Authors: Harry Bartelink, Jean-Claude Horiot, Philip Poortmans, H. Struikmans, Walter Van den Bogaert, I. Barillot, Alain Fourquet, Jacques Borger, J.J. Jager, W.J. Hoogenraad, Laurence Collette, M. Piérart - New England Journal of Medicine 2001 cited by 951

  16. Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial

    Authors: Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S. Fentiman, Roberto Agresti, Philippe Rouanet, C. Tunon de Lara, Harry Bartelink, N. Duez, Emiel J. Rutgers, Nina Bijker - Journal of Clinical Oncology 2013 cited by 379

  17. Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast Cancer

    Authors: Corey Speers, Shuang G. Zhao, Vishal Kothari, Alyssa Santola, Meilan Liu, Kari Wilder-Romans, Joseph R. Evans, Nidhi Batra, Harry Bartelink, Daniel F. Hayes, Theodore S. Lawrence, Powel H. Brown, Lori J. Pierce, Felix Y. Feng - Clinical Cancer Research 2016 cited by 135

  18. Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

    Authors: Saskia Litière, Gustavo Werutsky, Ian S. Fentiman, Emiel J. Rutgers, Marie-Rose Christiaens, Erik Van Limbergen, Margreet H.A. Baaijens, Jan Bogaerts, Harry Bartelink - The Lancet Oncology 2012 cited by 550

  19. Radiation-induced apoptosis

    Authors: Marcel Verheij, Harry Bartelink - Cell and Tissue Research 2000 cited by 288

  20. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’

    Authors: Sandra Collette, Laurence Collette, Tom Budiharto, Jean-Claude Horiot, Philip Poortmans, H. Struikmans, Walter Van den Bogaert, Alain Fourquet, J.J. Jager, W.J. Hoogenraad, Rolf‐Peter Mueller, John M. Kurtz, D.A.L. Morgan, Jean‐Bernard Dubois, E. Salamon, R.O. Mirimanoff, M. Bolla, Marleen van der Hulst, Carla C. Wárlám-Rodenhuis, Harry Bartelink - European Journal of Cancer 2008 cited by 224

  21. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial

    Authors: Conny Vrieling, Erik van Werkhoven, P. Maingon, Philip Poortmans, Caroline Weltens, Alain Fourquet, Dominic A.X. Schinagl, Bing Oei, C.C. Rodenhuis, Jean-Claude Horiot, H. Struikmans, Erik Van Limbergen, Youlia Kirova, Paula H.M. Elkhuizen, Rudolf Bongartz, Raymond Miralbell, D.A.L. Morgan, Jean‐Bernard Dubois, Vincent Remouchamps, René‐Olivier Mirimanoff, Guus Hart, Sandra Collette, Laurence Collette, Harry Bartelink - JAMA Oncology 2016 cited by 142

  22. Assessment of set-up variability during deep inspiration breath hold radiotherapy for breast cancer patients by 3D-surface imaging

    Authors: A. Betgen, Tanja Alderliesten, Jan‐Jakob Sonke, Corine van Vliet-Vroegindeweij, Harry Bartelink, P. Remeijer - Radiotherapy and Oncology 2013 cited by 99

  23. Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma-In-Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853—A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

    Authors: Nina Bijker, Philip Meijnen, Johannes L. Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S. Fentiman, Harry Bartelink, Emiel J. Rutgers - Journal of Clinical Oncology 2006 cited by 663

  24. Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials

    Authors: Adri C. Voogd, Maja Nielsen, Johannes L. Peterse, M Blichert-Toft, Harry Bartelink, Marie Overgaard, Geertjan van Tienhoven, Knud Andersen, Richard Sylvester, J.A. van Dongen - Journal of Clinical Oncology 2001 cited by 570